Want to learn more?  Please contact Keith Edwards, President & CEO.

[ NEWS ]

Precision Coating Announces Merger with N2 Biomedical to Expand Medical Coatings Platform

Hudson, MA (September 20, 2021) – Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets, is pleased to announce a merger with N2 Biomedical, a Bedford, MA-based company. N2 Biomedical, an Ampersand Capital Partners portfolio company, provides nano-engineered surface treatment and coating services to the medical device industry with its low-temperature Ion Implantation Surface […]

Read More
Exhibiting at NASS

N2 Biomedical Welcomes You to NASS 2021

  We are thrilled to announce that we’ll be exhibiting at NASS this year.  If you’ve got implants, then we’ve got something for you! NanoTitanium – our proprietary coating designed to: Promote bone growth and attachment Maintain mechanical properties Preserve radiolucency Create a strong bond and cohesion Include 360 surface coverage Visit booth #2535 to learn how this next generation […]

Read More

KEITH EDWARDS APPOINTED CHIEF EXECUTIVE OFFICER OF N2 BIOMEDICAL

Bedford, MA – June 29, 2021: N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, is pleased to announce that Keith Edwards has been appointed Chief Executive Officer. Mr. Edwards will assume leadership of all aspects of the organization and will oversee the implementation of N2’s growth strategy. Mr. Edwards brings a wealth […]

Read More
Spinal x-ray and medical implants.

N2 Biomedical awarded two patents for proprietary infection prevention, bone integration processes

Patents awarded for Dual Action NanoCoating, Mesoporous Surface for Enhanced Bone Integration BEDFORD, Mass. – June 29, 2020 – N2 Biomedical, a leading provider of coatings and surface treatment solutions to the medical device industry, was recently awarded two patents by the United States Patents Office: one for their proprietary Dual Action NanoCoating, and one for their Mesoporous Surface for […]

Read More

N2 Biomedical Announces The First Surgical Implant Of A Spinal Device Coated With The Company’s Thin, Ion-Assisted Titanium Coating Technology

BEDFORD, Mass., Jan. 14, 2021 /PRNewswire/ — N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, today announced that the first PEEK interbody fusion device coated with the company’s thin titanium coating technology was successfully implanted in a patient. The coated device had previously received 510(k) clearance from the U.S. FDA. N2 Biomedical’s thin titanium coating, […]

Read More

N2 Biomedical Featured in Orthopedic Design & Technology Article

In the Orthopedic Design & Technology magazine article “Making the Grade: Orthopedic Materials Spotlight”, author Mark Crawford discusses recent advancements with materials that are enabling the use of fabrication processes not previously available for certain applications, including N2 Biomedical’s proprietary surface modification treatments. Read the article here.

Read More

N2 Biomedical Appoints Eric Tobin To Chief Executive Officer

BEDFORD, Mass., Dec. 2, 2020 /PRNewswire/ — N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, today announced that its Board of Directors has appointed Eric Tobin to President and Chief Executive Officer. With more than 30 years of experience with the company, Mr. Tobin most recently served as the company’s Chief Operating Officer. In addition to […]

Read More
Metal orthopedic balls and joints

N2 Biomedical announces expansion of team, acquisition by Ampersand

Bedford-based company embraces recapitalization, internal team’s growth BEDFORD, Mass. – February 10, 2020 – N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, announced several personnel changes to support its growth following a recent majority recapitalization of the company by Ampersand Capital Partners. As part of the transaction, N2 Biomedical announced the appointments […]

Read More
Metal orthopedic balls and joints

Ampersand completes growth equity investment in N2 Biomedical

Bedford, MA – June 18, 2019: N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, announced today the majority recapitalization of the company by Ampersand Capital Partners. As part of the transaction N2 also announced the appointment of Randall Sword, an executive with 30 years of experience in the medical device sector, as […]

Read More